ARCHIVES

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

International Cancer Program Enthusiasm A Spinoff From U.S. Program, XIIth Congress Demonstrates

October 20, 1978

Ford Named Acting CORB Chief; Hunter CCOP Coordinator

July 10, 1987

DCT Board Approves Lung Cancer Drug Discovery Project, First Targeted Anticancer Agent Search

June 22, 1984

In Brief: “Massive Reassessment” Of Centers Going On, Tim Talbot Believes; WHO Drops ICRB Service

December 9, 1977

Byrd Seeks Federal Tar-Nicotine Limit

October 22, 1976

NCI Research Plan Proposes Spending $5 Billion In FY2002.

November 3, 2000